What initial laboratory tests should be ordered for a reproductive‑age female with secondary amenorrhea of ≥6 months and a negative pregnancy test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Laboratory Workup for Secondary Amenorrhea

Order a pregnancy test (urine or serum β-hCG), serum FSH, LH, prolactin, and TSH as your initial laboratory panel for any reproductive-age woman with secondary amenorrhea of ≥6 months and a negative pregnancy test. 1, 2, 3

Essential First-Line Laboratory Tests

Mandatory Initial Panel

  • Pregnancy test (urine β-hCG) – Must be performed first to exclude pregnancy, even with a reported negative test, as pregnancy remains the most common cause of amenorrhea in reproductive-age women 1, 2, 4

  • Serum follicle-stimulating hormone (FSH) – Distinguishes between ovarian failure (elevated FSH >25-40 IU/L indicating primary ovarian insufficiency) versus hypothalamic/pituitary dysfunction (low or normal FSH) 1, 2, 3

  • Serum luteinizing hormone (LH) – An LH:FSH ratio >2:1 strongly suggests polycystic ovary syndrome (PCOS), the most common cause of secondary amenorrhea in this population 1, 5

  • Serum prolactin – Hyperprolactinemia accounts for approximately 20% of secondary amenorrhea cases; draw as a single morning resting sample to avoid false elevations from stress or exercise 1, 2, 3

  • Serum thyroid-stimulating hormone (TSH) – Thyroid dysfunction is a reversible cause of amenorrhea and must be excluded in all cases 1, 2, 3

Additional Testing Based on Clinical Context

If Clinical Hyperandrogenism Present (Hirsutism, Acne, Male-Pattern Hair Loss)

  • Total testosterone – Levels >2.5 nmol/L warrant evaluation for androgen-secreting tumor; modest elevations (1.5-2.5 nmol/L) suggest PCOS 1, 5

  • DHEA-sulfate (DHEAS) – Helps exclude non-classical congenital adrenal hyperplasia if markedly elevated (>10.0 nmol/L) 1, 5

If Functional Hypothalamic Amenorrhea (FHA) Suspected

  • Estradiol level – Low estradiol (<30 pg/mL or <110 pmol/L) confirms hypoestrogenism and supports FHA diagnosis 1

  • Calculate energy availability – Document if patient consumes >30 kcal/kg fat-free mass/day; inadequate energy availability is the hallmark of FHA 1

If Amenorrhea Persists >6 Months

  • DXA scan for bone mineral density – Prolonged hypoestrogenic states significantly increase osteoporosis risk; 90% of peak bone mass is attained by age 18, making early assessment critical 1

Imaging Studies (Not Initial Bloodwork, But Often Concurrent)

  • Pelvic ultrasound (transvaginal preferred if sexually active) – Indicated when LH:FSH ratio >2, to assess for polycystic ovarian morphology, or to evaluate uterine/ovarian anatomy 1, 2

  • Pituitary MRI – Order only if prolactin remains elevated after excluding hypothyroidism, or if patient has headaches, visual changes, or galactorrhea suggesting pituitary pathology 1

Critical Red Flags Requiring Urgent Additional Workup

  • Severe hirsutism or virilization – Measure serum testosterone immediately; levels >2.5 nmol/L require evaluation for androgen-secreting tumor 1

  • Galactorrhea – Perform nipple expression during physical exam; if present with elevated prolactin, obtain pituitary MRI to exclude prolactinoma 1

  • Headaches or visual field defects – Obtain pituitary MRI urgently to rule out pituitary adenoma or other sellar mass 1

  • Weight loss >5% body weight in 6 months or BMI <18.5 kg/m² – Screen for eating disorders using validated tools; these patients require multidisciplinary eating disorder team referral 1, 5

Common Pitfalls to Avoid

  • Do not draw FSH/LH during oral contraceptive use – Stop hormonal contraceptives for at least 2 months before hormonal assessment, as they suppress normal FSH and LH patterns and render results uninterpretable 5

  • Do not draw prolactin post-exercise, post-stress, or post-seizure – These conditions cause transient elevations; ensure the sample is drawn as a morning resting value 1

  • Do not assume amenorrhea in athletes is benign – Even when clinical picture suggests FHA, other pathology (prolactinoma, PCOS, primary ovarian insufficiency) must be excluded with laboratory testing 1

  • Do not prescribe oral contraceptives before completing workup – OCPs mask the underlying problem without addressing the cause and make subsequent hormonal assessment impossible 1

Interpretation Algorithm Based on Initial Results

If FSH Elevated (>25-40 IU/L)

  • Diagnosis: Primary ovarian insufficiency – Confirm with repeat FSH in 4-6 weeks; these patients maintain unpredictable ovarian function and should not be presumed infertile 1, 2

If Prolactin Elevated

  • First exclude hypothyroidism by checking TSH; if TSH normal and prolactin persistently elevated, obtain pituitary MRI 1

If LH:FSH Ratio >2:1

  • Diagnosis: Polycystic ovary syndrome – Proceed with pelvic ultrasound and consider fasting glucose/insulin to assess metabolic syndrome risk 1, 5

If FSH/LH Both Low or Normal with Low Estradiol

  • Diagnosis: Functional hypothalamic amenorrhea – Assess for eating disorders, excessive exercise (>10 hours/week intense training), or significant psychosocial stressors 1

If All Hormones Normal

  • Perform progestin challenge test (medroxyprogesterone 10 mg daily for 10 days) – Withdrawal bleeding confirms adequate estrogen and patent outflow tract; absence of bleeding suggests either estrogen deficiency or anatomic obstruction 3, 6

References

Guideline

Amenorrhea Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Amenorrhea: an approach to diagnosis and management.

American family physician, 2013

Research

Evaluation of amenorrhea.

American family physician, 1996

Guideline

Management of Irregular Menstrual Cycles in Obese Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Amenorrhea: evaluation and treatment.

American family physician, 2006

Related Questions

What is the treatment approach for a female patient of reproductive age with amenorrhea and low Follicle-Stimulating Hormone (FSH) levels?
What laboratory tests should be ordered for a patient presenting with amenorrhea (absence of menstruation)?
What is the most appropriate initial investigation for a 45-year-old woman with amenorrhea (absence of menstruation) for 7 months, who has a negative pregnancy test and desires to become pregnant again?
What laboratory tests should be included in the initial evaluation of a patient presenting with amenorrhea?
What is the initial workup for a 38-year-old female (Gravida 1, Para 1) with amenorrhea, no birth control, and a negative urine pregnancy test, without symptoms of menopause or genitourinary issues?
I have had itchy, red eyes for three days after dirt exposure; what is the appropriate management?
What is the appropriate treatment for a patient with elevated serum free T4 and a normal TSH?
In an adult with type 2 diabetes and an estimated glomerular filtration rate of 15–60 mL/min/1.73 m², can Ozempic (semaglutide) be used, and what dosing and monitoring are recommended?
What are the differences in sedation depth and physiological effects between a target‑controlled infusion of propofol at 8 mg·kg⁻¹·h⁻¹ versus 10 mg·kg⁻¹·h⁻¹?
In a patient presenting with a first‑episode status epilepticus and a fever 10 days ago, whose cerebrospinal fluid shows a total cell count of 17 cells/µL with 90 % lymphocytes, normal glucose (99 mg/dL) and normal protein (41 mg/dL), what is the most likely diagnosis and initial management?
How long should maintenance immunotherapy be continued for a patient with neuromyelitis optica spectrum disorder who had an area‑postrema syndrome attack three years ago?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.